Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
352
-
Total 13F shares, excl. options
-
87.9M
-
Shares change
-
-2.03M
-
Total reported value, excl. options
-
$5.46B
-
Value change
-
-$130M
-
Put/Call ratio
-
0.21
-
Number of buys
-
156
-
Number of sells
-
-176
-
Price
-
$62.05
Significant Holders of RESMED INC - COM (RMD) as of Q4 2016
425 filings reported holding RMD - RESMED INC - COM as of Q4 2016.
RESMED INC - COM (RMD) has 352 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 87.9M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (11M shares), Capital World Investors (10.9M shares), BlackRock Fund Advisors (6.17M shares), BAILLIE GIFFORD & CO (5.05M shares), BlackRock Institutional Trust Company, N.A. (4.57M shares), STATE STREET CORP (4.5M shares), FMR LLC (3.94M shares), Bank of New York Mellon Corp (2.32M shares), COMMONWEALTH BANK OF AUSTRALIA (1.98M shares), and NORGES BANK (1.42M shares).
This table shows the top 352 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.